Frontiers | Biological Markers in Early Multiple Sclerosis: the Paved Way for Radiologically Isolated Syndrome
Study uncovers markers for severe form of multiple sclerosis | YaleNews
Precision medicine in multiple sclerosis | LiveWiseMS
The Role of Transcranial Magnetic Stimulation as a Surrogate Marker of Disease Activity in Patients with Multiple Sclerosis: A Literature Review - Innovations in Clinical Neuroscience : Innovations in Clinical Neuroscience
Slowly expanding lesions are a marker of progressive MS – No - Douglas L Arnold, Shibeshih Belachew, Arie R Gafson, Laura Gaetano, Corrado Bernasconi, Colm Elliott, 2021
JCI Insight - Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine–induced antibody and T cell immunity and function
![PDF] Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6a911c07c250fb50f3cc1d13d73c33bf5889e380/5-Table4-1.png "PDF] Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity | Semantic Scholar")
PDF] Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity | Semantic Scholar
Disturbed regulatory T cell homeostasis in multiple sclerosis: Trends in Molecular Medicine
Markers of neurodegeneration in multiple sclerosis | Download Table
Biomarkers in Multiple Sclerosis - Practical Neurology
Frontiers | Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
Thinking outside the box: non-canonical targets in multiple sclerosis | Nature Reviews Drug Discovery
Biomarkers in Multiple Sclerosis - Practical Neurology
Expression of M1 and M2 markers in active multiple sclerosis (MS)... | Download Scientific Diagram
numares and Oxford University sign exclusive license agreement for novel multi-marker diagnostics in multiple sclerosis | Business Wire
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis | Nature Communications
Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age - eBioMedicine
New prognostic marker discovered for multiple sclerosis severity
Targeting a rogue T cell prevents and reverses multiple sclerosis in mice
Molecular biomarkers in multiple sclerosis | Journal of Neuroinflammation | Full Text
Frontiers | Mechanistic and Biomarker Studies to Demonstrate Immune Tolerance in Multiple Sclerosis
Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis - eBioMedicine
Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis - ScienceDirect
